KATO III/Cre cells are derived from human gastric cancer cell line KATO III by stably integration of a constitutive Cre recombinase stably expression construct. KATO III cells are valuable for studying gastric cancer biology, including the mechanisms of tumor growth, metastasis, and response to therapies. KATO III/Cre cells stably express a nuclear localized Cre recombinase.